Skip to main navigation Skip to search Skip to main content

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma

  • Kristine A. Frerichs
  • , Monique C. Minnema
  • , Mark David Levin
  • , Annemiek Broijl
  • , Gerard M.J. Bos
  • , Marie Jose Kersten
  • , Tuna Mutis
  • , Christie P.M. Verkleij
  • , Inger S. Nijhof
  • , Patricia W.C. Maas-Bosman
  • , Saskia K. Klein
  • , Sonja Zweegman
  • , Pieter Sonneveld
  • , Niels W.C.J. Van de Donk*
  • *Corresponding author for this work
  • Vrije Universiteit Amsterdam
  • University Medical Centre Utrecht
  • Maastricht University
  • Albert Schweitzer Ziekenhuis
  • Amsterdam UMC
  • Meander Medical Center
  • University Medical Centre Groningen

Research output: Contribution to journalArticleAcademicpeer-review

32 Citations (Scopus)
59 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology